Delta Variant of Covid-19 and Hearing Loss

被引:0
|
作者
Abishek Umashankar
Praveen Prakash
Prashanth Prabhu
机构
[1] All India Institute of Speech and Hearing Mysuru,Department of Audiology
[2] All India Institute of Speech and Hearing Mysuru,undefined
关键词
Delta variant; Hearing loss; Thrombosis; Cross reaction; Hearing care management;
D O I
暂无
中图分类号
学科分类号
摘要
The Coronavirus Disease of 2019 has now become one of the biggest pandemics of all time. Under the influence of ongoing mutations and widespread geographical expansions, several variants have been reported. Among those, the B.1.617.2 variant, most commonly known as the ‘Delta variant’ of the coronavirus disease – 19, was first reported in the state of Maharashtra of India in December 2020 and have currently been detected in over 43 countries across six continents around the globe. The B.1.617.2 variant of COVID 19 is a more treacherous variant than the alpha variant due to the increased replication leading to higher viral loads and increased transmission with minimal literature reporting about vaccines’ efficacy. In patients with the Alpha variant of COVID-19, hearing loss was an infrequent symptom seen, but on the other hand, the Delta variant happens to have a more frequent hearing loss as a symptom. The increased severity could be one of the reasons why hearing loss could be a typically seen symptom with high chances of occurrence of either a thrombosis, cross-reaction, labyrinthitis/neuritis, etc. and thus audiologists and otolaryngologists must be prepared for the post effect of the delta variant to evaluate and rehabilitate the individuals affected with hearing loss. The following article discusses the presence of hearing loss in individuals with delta variant of COVID 19 and the role of audiologists and otolaryngologists in hearing care.
引用
收藏
页码:2634 / 2636
页数:2
相关论文
共 50 条
  • [21] Delta Variant of Covid-19 Study, and Why it is a Concern: An Overview
    Monajjemi, Majid
    Kandemirli, Fatma
    Mollaamin, Fatemeh
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2022, 12 (05): : 5797 - 5810
  • [22] The challenges of COVID-19 Delta variant: Prevention and vaccine development
    He, Xuemei
    He, Cai
    Hong, Weiqi
    Zhang, Kang
    Wei, Xiawei
    MEDCOMM, 2021, 2 (04): : 846 - 854
  • [23] Clinical characteristics of the delta variant of COVID-19 in Jingmen, China
    Bie, Fangfang
    Yuan, Wensheng
    Chen, Yafeng
    Gao, Qijun
    MEDICINE, 2022, 101 (38) : E30812
  • [24] COVID-19 delta variant and anxiety and fear in pregnant women
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JOURNAL OF PERINATAL MEDICINE, 2022, 50 (02) : 228 - 228
  • [25] COVID-19: risk factors for severe cases of the Delta variant
    Hu, Kaiyuan
    Lin, Liu
    Liang, Ying
    Shao, Xinning
    Hu, Zhongwei
    Luo, Hongbin
    Lei, Ming
    AGING-US, 2021, 13 (20): : 23459 - 23470
  • [26] The Delta Variant Triggers the Third Wave of COVID-19 in Mexico
    De La-Cruz Hernandez, Sergio Isaac
    Barrera-Badillo, Gisela
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2023, 16 (06) : 2225 - 2227
  • [27] Comparing Omicron and Delta variant phenotypes of severe COVID-19
    Wagener, Gebhard
    Mitsui, Erika
    ANESTHESIA AND ANALGESIA, 2023, 136 : 167 - 169
  • [28] Analysis of the Delta Variant B.1.617.2 COVID-19
    Shiehzadegan, Shayan
    Alaghemand, Nazanin
    Fox, Michael
    Venketaraman, Vishwanath
    CLINICS AND PRACTICE, 2021, 11 (04) : 778 - 784
  • [29] Mycoplasma pneumoniae COVID-19 Delta Variant Co-Infection Mimicking COVID-19 ARDS
    Crosby, James
    Semon, Sarah
    Ganti, Subramanya Shyam
    Klauber-Choephel, Enid
    Abraham, James
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10
  • [30] COVID-19 and Sudden Sensorineural Hearing Loss: A Systematic Review
    Meng, Xiangming
    Wang, Jing
    Sun, Jian
    Zhu, Kangxu
    FRONTIERS IN NEUROLOGY, 2022, 13